Editorial: Cross-reactive immunity and COVID-19
2024

Cross-reactive immunity and COVID-19

Editorial

Author Information

Author(s): Vojdani Aristo, Yaqinuddin Ahmed, Beretta Alberto, Reche Pedro A.

Conclusion

Pre-existing cross-reactive immunity may influence the immune response to COVID-19 and its vaccines, but its exact contribution to protection is still unclear.

Supporting Evidence

  • Cross-reactive immunity can come from past infections or vaccines and may help against COVID-19.
  • Some studies suggest that childhood vaccines might protect against COVID-19.
  • Research shows that the immune response to COVID-19 vaccines can also create cross-reactive responses.

Takeaway

Some people might have immunity to COVID-19 because of past infections or vaccines, but we still need to learn how much this helps against new virus versions.

Limitations

The exact impact of cross-reactive immunity on COVID-19 protection is still undetermined.

Digital Object Identifier (DOI)

10.3389/fimmu.2024.1509379

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication